当前位置:首页 - 行情中心 - 华大基因(300676) - 财务分析 - 现金流量表

华大基因

(300676)

  

流通市值:160.43亿  总市值:161.71亿
流通股本:4.13亿   总股本:4.16亿

现金流量表

报告期2024-09-302024-06-302024-03-312023-12-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
销售商品、提供劳务收到的现金2,312,310,695.981,509,250,509.84678,413,231.824,907,751,773.51
收到的税费返还2,755,600.382,754,217.07702,086.1729,369,879.22
收到其他与经营活动有关的现金226,792,137.3155,532,111.5997,996,066.65194,614,881.91
经营活动现金流入的平衡项目0000
经营活动现金流入小计2,541,858,433.661,667,536,838.5777,111,384.645,131,736,534.64
购买商品、接受劳务支付的现金1,057,292,663.53649,285,838.08311,556,439.031,946,420,301.68
支付给职工以及为职工支付的现金925,531,974.13634,754,891.07344,153,214.011,328,746,612.59
支付的各项税费135,466,714.45104,836,253.0643,234,686.47174,173,341.2
支付其他与经营活动有关的现金566,379,433.63359,136,677.41154,104,406.711,273,628,427.8
经营活动现金流出的平衡项目0000
经营活动现金流出小计2,684,670,785.741,748,013,659.62853,048,746.224,722,968,683.27
经营活动产生的现金流量净额平衡项目0000
经营活动产生的现金流量净额-142,812,352.08-80,476,821.12-75,937,361.58408,767,851.37
二、投资活动产生的现金流量:
收回投资收到的现金7,580,390,516.793,565,558,577.151,070,048,204.513,332,077,841.45
取得投资收益收到的现金76,456,772.439,576,941.728,337,985.15240,245,823.66
处置固定资产、无形资产和其他长期资产收回的现金净额4,289,214.394,229,537.234,087,044.232,716,450
收到的其他与投资活动有关的现金---11,736,557.69
投资活动现金流入的平衡项目0000
投资活动现金流入小计7,661,136,503.583,609,365,056.11,082,473,233.893,586,776,672.8
购建固定资产、无形资产和其他长期资产支付的现金364,136,982.78196,062,319.31109,149,926.711,236,385,209.3
投资支付的现金7,824,082,496.953,357,396,010.441,557,082,297.054,095,787,296.21
支付其他与投资活动有关的现金---5,344,949.77
投资活动现金流出的平衡项目0000
投资活动现金流出小计8,188,219,479.733,553,458,329.751,666,232,223.765,337,517,455.28
投资活动产生的现金流量净额平衡项目0000
投资活动产生的现金流量净额-527,082,976.1555,906,726.35-583,758,989.87-1,750,740,782.48
三、筹资活动产生的现金流量:
取得借款收到的现金161,376,240.15113,088,937.0532,399,758.83251,678,162.82
收到其他与筹资活动有关的现金53,078,767.553,078,767.5-82,850,551.84
筹资活动现金流入平衡项目0000
筹资活动现金流入小计214,455,007.65166,167,704.5532,399,758.83334,528,714.66
偿还债务支付的现金22,792,473.4613,500,0006,000,00012,000,000
分配股利、利润或偿付利息支付的现金50,834,608.286,883,432.311,776,787.3416,734,734.9
其中:子公司支付给少数股东的股利、利润3,181,5003,181,500--
支付其他与筹资活动有关的现金457,640,013.93443,493,138.5921,958,174.42172,676,186.77
筹资活动现金流出平衡项目0000
筹资活动现金流出小计531,267,095.67463,876,570.929,734,961.72601,410,921.67
筹资活动产生的现金流量净额平衡项目0000
筹资活动产生的现金流量净额-316,812,088.02-297,708,866.352,664,797.11-266,882,207.01
四、汇率变动对现金及现金等价物的影响19,769,275.4521,750,618.4312,789,626.1932,822,168.03
现金及现金等价物净增加额平衡项目0000
五、现金及现金等价物净增加额-966,938,140.8-300,528,342.69-644,241,928.15-1,576,032,970.09
加:期初现金及现金等价物余额3,555,141,076.983,555,141,076.983,555,141,076.985,131,174,047.07
期末现金及现金等价物余额平衡项目0000
期末现金及现金等价物余额2,588,202,936.183,254,612,734.292,910,899,148.833,555,141,076.98
补充资料:
净利润-20,153,227.36-93,681,843.43
资产减值准备-60,685,522.23-96,273,989.03
固定资产和投资性房地产折旧-181,009,572.35-312,206,699.84
其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-181,009,572.35-312,206,699.84
无形资产摊销-32,483,252.66-57,607,586.97
长期待摊费用摊销-24,800,327.22-36,145,952.84
处置固定资产、无形资产和其他长期资产的损失--2,685,435.04--2,763,827.65
固定资产报废损失-3,764,822.08-5,711,218.48
公允价值变动损失-7,105,994.48-34,357,341.9
财务费用-15,403,515.82-66,676,273.68
投资损失-11,089,127.82--1,284,630.6
递延所得税--21,701,774.89-24,938,090.76
其中:递延所得税资产减少--21,152,344.92-15,316,543.17
递延所得税负债增加--549,429.97-9,621,547.59
存货的减少-849,789.6-103,781,748.13
经营性应收项目的减少--477,583,050.76-736,488,070.75
经营性应付项目的增加-33,953,885.33--1,344,884,203.19
其他---122,809,861.85
债务转为资本---46,494,875
不涉及现金收支的投资和筹资活动金额其他项目-9,833,858.05-41,710,934
现金的期末余额-3,254,612,734.29-3,555,141,076.98
减:现金的期初余额-3,555,141,076.98-5,131,174,047.07
公告日期2024-10-262024-08-242024-04-272024-04-13
审计意见(境内)标准无保留意见
TOP↑